ERBB2 and breast neoplasm: In addition, for prognostic and predictive purposes, all invasive breast tumours are tested for expression of the oestrogen receptor (ER) and progesterone receptor (PR) as well as for overexpression of the human epidermal growth factor receptor 2 (HER2).